XOMA Corp (NASDAQ:XOMA) gained 8.14% as the company will host a conference call on Wednesday, May 7, 2014, at 4:30 p.m. Eastern time to discuss first quarter 2014 financial results and provide an update on gevokizumab’s global clinical programs. XOMA Corp (NASDAQ:XOMA) opened today at $4.62 and is currently trading at $4.52. The stock showed a positive weekly performance of 21.73%.
Pharmacyclics, Inc. (NASDAQ:PCYC) surged 8.00% as the company recently reported its first quarter earnings results. For the quarter, Pharmacyclics reported total revenue of $119.4 million, a more than 40-fold increase from the $2.8 million in revenue reported in the year-ago period. This was comprised of $56.2 million in Imbruvica sales following its first full quarter as an approved therapy for mantle cell lymphoma and $60 million in milestone payments from marketing partners Janssen Biotech, a subsidiary of Johnson & Johnson (NYSE:JNJ). Pharmacyclics, Inc. (NASDAQ:PCYC) opened at $94.61, in current trading session and currently is at $93.15, by losing -2.27%. The 52 week range of $74.36 – 154.89. Company’s market capitalization is $7.14 billion.
Ironwood Pharmaceuticals (NASDAQ:IRWD) stock had its “overweight” rating reaffirmed by research analysts at JPMorgan Chase & Co. in a report released on Wednesday, Analyst Ratings Network.com reports. They currently have a $22.00 price objective on the stock. JPMorgan Chase & Co.’s target price suggests a potential upside of 90.81% from the stock’s previous close. Ironwood Pharmaceuticals, Inc.(NASDAQ:IRWD) stock is currently trading at $12.15. The EPS of the stock is -1.90 Company’s market capitalization is $1.72 billion.
GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) jumped 7.86% after the announcement on Monday that its Sativex drug treatment had received a “fast track” designation from regulators at the Food and Drug Administration. Sativex, a cannaboid based treatments that is comprised of CBD (cannabidiol) and THC, is designed to treat pain associated with advanced stages of cancer. It is currently in Phase 3 clinical trials. GW Pharmaceuticals PLC- ADR(NASDAQ:GWPH) stock opened the session at $76.75, and now is at $. The 52 week range of the GWPH stock remained $ 8.46 – 86.45 and the day range was $1.76 – $1.98.